Saturday, October 31, 2026

FDA Approves Zaynich (cefepime and zidebactam) for the Treatment of Complicated Urinary Tract Infections

›
In continuation of my update on  cefepime cefepime Zidebactam FDA approved Zaynich (cefepime and zidebactam), a novel intravenous antibiotic...
Friday, October 30, 2026

FDA Approves Xocova (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure

›
In continuation of my update on  ensitrelvir Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, P...
Thursday, October 29, 2026

Psilocybin to target persistent concussion symptoms in Australia's first clinical trial

›
In continuation of my update on  psychedelic Monash University researchers have launched Australia's first clinical trial to test whethe...
Wednesday, October 28, 2026

Baricitinib Exhibits Steroid-Sparing Effect in PMR Trial

›
In coninuation of my update on Baricitinib Baricitinib had a significant glucocorticoid (GC)-sparing effect in people with newly diagnosed p...
Tuesday, October 27, 2026

Psilocybin linked to reduction in depression

›
In continuation of my update on  Psilocybin   A study of 19 patients with treatment-resistant depression treated with psilocybin in Switzerl...
Saturday, October 24, 2026

Drug duo synergy may help cystic fibrosis patients clear lung mucus, animal tests suggest

›
Two existing types of drugs synergize to improve the clearing of mucus from the lungs of animals with cystic fibrosis, a Stanford Medicine r...
Thursday, October 22, 2026

Acetaminophen reaffirmed as first-line medication for treating pain and fever during pregnancy

›
In continuation of my update on acetaminophen  Acetaminophen remains the recommended first-line medication to treat pain and fever during p...
Monday, October 19, 2026

With trial success, Gilead paves way for broader use of Livdelzi

›
A phase 3 study of Gilead’s Livdelzi has met its primary endpoint, showing the drug's ability to normalize a key marker of disease progr...
Thursday, October 15, 2026

Chia seeds show promise in supporting heart health, metabolic function

›
Chia seeds: A superfood for cardiometabolic health Chia seeds, long a dietary staple in Mesoamerican cultures dating back to the Aztecs and ...
Wednesday, October 14, 2026

China approves fruquintinib combination for kidney cancer

›
China’s National Medical Products Administration (NMPA) has approved a combination of ELUNATE (fruquintinib) and TYVYT (sintilimab) for pati...